Capsulas
Welcome to CAPSULAS, our newsletter in which, since 1997, we have been informing clients and friends about novelties of interest in the area of pharmaceutical law in Spain and in the European Union.
New rules for conducting observational studies with medicines in Spain: less complexity and more transparency
Royal Decree 957/2020, of 3 November, which regulates observational studies with medicines for human use
Eduard Rodellar
Capsulas Especial
New version of the Code of Practice for the Pharmaceutical Industry of Farmaindustria
The new version of the Code of Practice has come into force on 1 January 2021
Jordi Faus, Verónica Carías and Laura Marquès
Capsulas Especial
Approval process for COVID-19 vaccines
On the occasion of the grant of the marketing authorization to Comirnaty®, the vaccine developed by BioNTech and Pfizer
Jordi Faus, Oriol Cases
Capsulas Especial
Can an administrative act be executed pending an internal administrative appeal?
Judgment of Supreme Court of 28 May 2020
Juan Martínez
Capsulas Nº 212
Reimbursement of cross-border healthcare costs without the prior authorization of the Member State of Affiliation
Judgement of the European Court of Justice of 23 September 2020, WO v Vas Megyei Kormányhivatal, Case C-777/18
Eduard Rodellar
Capsulas Nº 212
Commercial interests and access to documents
Resolution 352/2020 of the Council of Transparency and Good Governance of 15 September 2020
Joan Carles Bailach
Capsulas Nº 212
Rebus sic stantibus
Draft law on procedural and organizational measures to confront the COVID-19 in the Administration of Justice
Xavier Moliner, Juan Martínez